1660963-42-7,
RX-518,
N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide,
EGFR-IN-3,
UNII-708TLB8J3Y,
708TLB8J3Y,
CK-101,
AK543910,
2-Propenamide, N-(3-(2-((2,3-difluoro-4-(4-(2-hydroxyethyl)-1-piperazinyl)phenyl)amino)-8-quinazolinyl)phenyl)-,
2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-,
N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide,
GTPL9863,
SCHEMBL16514522,
KS-00000TOQ,
IDRGFNPZDVBSSE-UHFFFAOYSA-N,
BDBM318916,
CK101,
RX518,
BCP19075,
EX-A1142,
MFCD30345533,
RX 518,
US10172868, Compound C151,
AKOS030632731,
ZINC514250913,
DS-19272,
HY-19815,
CS-0016788,
Example 153 [US20170050936A1],
J-690231,
[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid,
N-(3-(2-(2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)quinazolin-8-yl)phenyl)acrylamide,
RX518(CK-101),1660963-42-7,,CK101,CK-101,CK 101,RX518,RX-518,RX 518,